Secondary Logo

Share this article on:

Hormone Receptors in Microglandular Hyperplasia of the Uterine Cervix

Zamecnik, Michal M.D.

International Journal of Gynecological Pathology: October 2002 - Volume 21 - Issue 4 - p 424-425
LETTERS TO THE EDITOR

Sikls's Department of Pathology,

Faculty Hospital, Charles University,

Pilsen, Czech Republic

To the Editor:

Microglandular hyperplasia (MGH) of the cervix can mimic cervical and endometrial adenocarcinomas that have a pattern resembling that of MGH, especially in a curettage or biopsy specimen (1). Although pure MGH-like uterine carcinomas are rare (2–5), a focal microglandular pattern in endometrial endometrioid adenocarcinomas is quite frequent (12% in the study by Jacques et al.) (6). Inspired by the recent use of hormone receptor immunostains in the differential diagnosis of uterine carcinomas by McCluggage et al. (7), I have wondered whether such immunostains could help in the differential diagnosis between MGH and microglandular endometrial and endocervical adenocarcinomas. Because I did not find in the Medline database any data on hormone receptor immunohistochemistry in MGH, I have performed these stains in eight cases of cervical MGH. The patients had an average age of 40.5 (range 25–59) years. All patients but one were premenopausal. Clinical diagnoses were CIN with cervical polyp in three cases, cervical polyp in three cases, and CIN in two cases. In all cases, a simple excision of the lesion was performed. All of the lesions showed the histologic features of MGH (1), which was synchronous with high-grade CIN in five. The epithelium of MGH in all but one case was completely negative for progesterone receptor (PR) (1A6, Immunotech, Marseilles, France) (Fig. 1). The exception was a case with slight and equivocal positivity in 30% of the cells. Estrogen receptor (ER) (1D5, Immunotech) was strongly positive in 80–100% of epithelial cells in all of the lesions (Fig. 2). The stromal cells were always strongly positive for PR and variably positive for ER. Thus, MGH is a typically ER+/PR− lesion. In contrast, endometrial adenocarcinomas (especially the well-differentiated ones that often contain MGH-like foci) express PR in a majority of cases (8–10). Cervical adenocarcinomas, which can also mimic MGH, are usually negative or only slightly positive for ER (7) in contrast with the consistent ER positivity of MGH.

FIG. 1.

FIG. 1.

FIG. 2.

FIG. 2.

Michal Zamecnik, M.D.

Back to Top | Article Outline

REFERENCES

1. Nichols TM, Fidler HK. Microglandular hyperplasia in cervical cone biopsies taken for suspicious and positive cytology. Am J Clin Pathol 1971; 56:424–9.
2. Young RH, Scully RE. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992; 16:1092–7.
3. Zaloudek C, Hayashi GM, Ryan IP, Powell CB, Miller TR. Microglandular adenocarcinoma of the endometrium: a form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathol 1997; 16:52–9.
4. McCluggage WG, Perenyei M. Microglandular adenocarcinoma of the endometrium. Histopathology 2000; 37:285–7.
5. Fukunaga M. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix. Pathol Int 2000; 50:541–5.
6. Jacques SM, Qureshi F, Lawrence WD. Surface epithelial changes in endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens. Int J Gynecol Pathol 1995; 14:191–7.
7. McCluggage WG, Sumathi VP, McBride HA, Patterson A. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, AIDS the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002; 21:11–5.
8. Halperin R, Zehavi S, Habler L, Hadas E, Bukovsky I, Schneider D. Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium. Eur J Gynaecol Oncol 2001; 22:122–6.
9. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation. Hum Pathol 1998; 29:924–31.
10. Koshiyama M, Konishi I, Wang DP, et al. Immunohistochemical analysis of p53 protein over-expression in endometrial carcinomas: inverse correlation with sex steroid receptor status. Virchows Arch A Pathol Anat Histopathol 1993; 423:265–71.
©2002International Society of Gynecological Pathologists